American Oncology Network Statistics
Share Statistics
American Oncology Network has 44.12M
shares outstanding. The number of shares has increased by 165.46%
in one year.
| Shares Outstanding | 44.12M |
| Shares Change (YoY) | 165.46% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 81 |
| FTD / Avg. Volume | 5.28% |
Short Selling Information
The latest short interest is 10.81K, so undefined% of the outstanding
shares have been sold short.
| Short Interest | 10.81K |
| Short % of Shares Out | n/a |
| Short % of Float | 0.05% |
| Short Ratio (days to cover) | 0.63 |
Valuation Ratios
The PE ratio is -17.47 and the forward
PE ratio is null.
American Oncology Network's PEG ratio is
0.07.
| PE Ratio | -17.47 |
| Forward PE | n/a |
| PS Ratio | 0.04 |
| Forward PS | n/a |
| PB Ratio | -1.5 |
| P/FCF Ratio | -2.68 |
| PEG Ratio | 0.07 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for American Oncology Network.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.53,
with a Debt / Equity ratio of -1.28.
| Current Ratio | 1.53 |
| Quick Ratio | 1.25 |
| Debt / Equity | -1.28 |
| Debt / EBITDA | -3.38 |
| Debt / FCF | -2.28 |
| Interest Coverage | -2.47 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $919,270.64 |
| Profits Per Employee | $-2,075.76 |
| Employee Count | 1,914 |
| Asset Turnover | 3.74 |
| Inventory Turnover | 27.04 |
Taxes
| Income Tax | 2.5M |
| Effective Tax Rate | -35.56% |
Stock Price Statistics
The stock price has increased by -12.71% in the
last 52 weeks. The beta is 0.54, so American Oncology Network's
price volatility has been higher than the market average.
| Beta | 0.54 |
| 52-Week Price Change | -12.71% |
| 50-Day Moving Average | 5.12 |
| 200-Day Moving Average | 3.84 |
| Relative Strength Index (RSI) | 40.04 |
| Average Volume (20 Days) | 1,535 |
Income Statement
In the last 12 months, American Oncology Network had revenue of 1.76B
and earned -3.97M
in profits. Earnings per share was 1.85.
| Revenue | 1.76B |
| Gross Profit | 117.85M |
| Operating Income | -17.43M |
| Net Income | -3.97M |
| EBITDA | -17.43M |
| EBIT | -17.56M |
| Earnings Per Share (EPS) | 1.85 |
Full Income StatementBalance Sheet
The company has 62.85M in cash and 58.98M in
debt, giving a net cash position of 3.87M.
| Cash & Cash Equivalents | 62.85M |
| Total Debt | 58.98M |
| Net Cash | 3.87M |
| Retained Earnings | -102.17M |
| Total Assets | 470.33M |
| Working Capital | 114.63M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -4.94M
and capital expenditures -20.95M, giving a free cash flow of -25.9M.
| Operating Cash Flow | -4.94M |
| Capital Expenditures | -20.95M |
| Free Cash Flow | -25.9M |
| FCF Per Share | -1.89 |
Full Cash Flow StatementMargins
Gross margin is 6.7%, with operating and profit margins of -0.99% and -0.23%.
| Gross Margin | 6.7% |
| Operating Margin | -0.99% |
| Pretax Margin | -0.4% |
| Profit Margin | -0.23% |
| EBITDA Margin | -0.99% |
| EBIT Margin | -0.99% |
| FCF Margin | -1.47% |
